ADVA
21.9.2021 09:02:50 CEST | Business Wire | Press release
ADVA (FSE: ADV) and SIA, Indra’s cybersecurity company, today announced that RedIRIS is deploying ADVA’s technology to create a robust, high-capacity research and education network (NREN). The new long-haul backbone infrastructure connects universities and research facilities across Spain, enabling educators and scientists to share huge data sets and harness bandwidth-intensive applications. Built on the ADVA FSP 3000 and monitored by the ADVA ALM fiber assurance solution, the network carries services at speeds up to 200Gbit/s. Featuring ADVA’s ROADM technology and QuadFlex™ line cards, the open solution has given RedIRIS an easy way to migrate from legacy technology to flexible, high-performance connectivity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005058/en/
“Our new transport system empowers Spain’s scientists and academics to work together on national and international projects under optimum conditions. With flexible coherent wavelengths up to 200Gbit/s, it provides secure, highly reliable access to everything from video conferencing tools to high-performance remote computing facilities,” said Esther Robles, head of communications networks, RedIRIS. “ADVA’s open FSP 3000 technology enabled a smooth and painless transition from our existing transport infrastructure. With its modular design, it also provides massive scale, giving us the freedom to easily expand and evolve our network to meet future needs.”
Connecting more than 80 points of presence and over 500 institutions, RedIRIS’s new backbone network includes long-haul single-span submarine links to Spain’s Balearic Islands and the city of Melilla, as well as connections to the Canary Islands, the Canarian Institute of Astrophysics and its observatories. For flexibility and high spectral efficiency, the solution features ADVA’s flexgrid multi-degree ROADMs, enabling high-speed coherent and high-baud-rate transport. Through ADVA’s MicroMux™ technology, the new infrastructure also supports a seamless mix of 10Gbit/s and 100Gbit/s Ethernet client ports without any footprint increase. This optimizes space efficiency and ensures no stranded bandwidth. The network upgrade also involved the deployment of a solid and thorough migration plan by SIA, a leading Indra company in cybersecurity and ADVA’s Select partner.
“RedIRIS’s long-haul infrastructure is now one of Europe’s most advanced NRENs. It will enable researchers and teachers in Spain to leverage a new breed of data-intensive applications and collaborate in new ways using innovative video conferencing and augmented reality tools,” commented Hartmut Müller-Leitloff, SVP, sales, EMEA, ADVA. “Our open and scalable technology efficiently bridges the gap between the legacy needs and the future demand of RedIRIS’s users. Its unique client port flexibility supports a mix of 10Gbit/s and 100Gbit/s Ethernet services without the need for additional hardware. With our open optical layer, RedIRIS is also free to tackle rising demands in the future by expanding to higher baud rates and more complex modulation schemes.”
“For the design and deployment of a complex project like this, it has been key to walk hand in hand with our client RedIRIS, to perfectly understand its requirements and choose the right professionals with the knowledge and capacity to migrate to a new network that meets the organization’s present and future needs for a wide range of services. The project allows RedIRIS to carry encoded critical services that assure a greater level of cybersecurity with no latency,” stated Alejandro Díez, director, digital risk, SIA. “This deployment gives RedIRIS’s users in the research and scientific community an extremely powerful tool for high-quality collaboration and global connectivity. It also prepares Spain’s NREN for the key challenges of the future as it looks to connect more schools, universities, research centers, global libraries, smart cities and IoT. RedIRIS will operate as a critical infrastructure and will assure an immediate communication service with any other geographic point of the network, with robust processes and higher cybersecurity.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
About Indra
Indra is one of the leading global technology and consulting companies and the technological partner for core business operations of its customers world-wide. It is a world-leader in providing proprietary solutions in specific segments in Transport and Defense markets, and a leading firm in Digital Transformation and Information Technologies in Spain and Latin America through its affiliate Minsait. Its business model is based on a comprehensive range of proprietary products, with a high-value focus and with a high innovation component. In the 2020 financial year, Indra achieved revenue of €3.043 billion, near 48,000 employees, a local presence in 46 countries and business operations in over 140 countries. www.indracompany.com
About SIA
SIA is the Indra company leading the cybersecurity sector in Spain and Portugal, both in terms of turnover and expert talent, with more than 1,200 specialists. Its value proposition is based on the specific responses it offers organizations to meet the challenges and threats posed by the four forces of digitalization: regulatory pressure, connected infrastructures, the transformation of IT architectures and the growing digital interaction of people; responses articulated through a set of specific measures and plans to minimize risk and maximize the protection of their businesses. Being a member of the Indra Group, one of the leading global technology and consultancy companies with business operations in 140 countries, provides SIA with a profound knowledge of the industries as well as a solid worldwide presence. Further information at www.sia.es .
About RedIRIS
RedIRIS is the Spanish academic and research network that provides advanced communication services to the scientific community and national universities. It is funded by the Ministry of Science and Innovation and is included in the Ministry’s map of Special Scientific and Technological Facilities (ICTS). It is managed by the Public Corporate Entity Red.es, which reports to the Ministry of Economic Affairs and Digital Transformation. RedIRIS has over 500 affiliated institutions, mainly universities and public research centres, which join this community by signing an affiliation agreement. www.rediris.es
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210921005058/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership4.8.2026 11:00:00 CEST | Press release
The integration gives eligible WHOOP members seamless access to the only FDA-cleared hormone-free birth control app, with the first year of Natural Cycles° included for those new to the app as part of their WHOOP membership. WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804399367/en/ WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership The Natural Cycles app, a Class II medical device, u
Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 10:00:00 CEST | Press release
Acquisitions Expand Transfer Pricing Offering and Support Long-Term Platform Strategy Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphata
LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 09:10:00 CEST | Press release
LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The
“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 09:00:00 CEST | Press release
Giant Hatsune Miku Returns to Light Up Tokyo’s Night! The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 09:00:00 CEST | Press release
Accomplished life sciences leader with a proven track record of driving successful development of novel therapeutics, joins Mosaic to guide its next phase of growthAllison brings three decades of drug development, board and executive leadership experience to support Mosaic’s transition towards a clinical-stage company Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 year
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom